JB0112
2021-10-22
ok
3 Stocks to Keep an Eye on Ahead of Next Week's Earnings
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":851215189,"tweetId":"851215189","gmtCreate":1634910484486,"gmtModify":1634910485570,"author":{"id":3585877031221506,"authorId":3585877031221506,"authorIdStr":"3585877031221506","name":"JB0112","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":5,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>ok</p></body></html>","htmlText":"<html><head></head><body><p>ok</p></body></html>","text":"ok","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/851215189","repostId":2177497008,"repostType":4,"repost":{"id":"2177497008","pubTimestamp":1634904901,"share":"https://www.laohu8.com/m/news/2177497008?lang=&edition=full","pubTime":"2021-10-22 20:15","market":"us","language":"en","title":"3 Stocks to Keep an Eye on Ahead of Next Week's Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2177497008","media":"Motley Fool","summary":"I'll discuss the three stocks I'll be watching ahead of next week's earnings: Facebook(FB), Twitter(","content":"<p> I'll discuss the three stocks I'll be watching ahead of next week's earnings: <b>Facebook(FB)</b>, <b>Twitter(TWTR)</b>, and <b>Teladoc</b>. </p>\n<h2>Facebook</h2>\n<p>Last quarter it was all about the metaverse and how Mark Zuckerberg wants Facebook to become a metaverse company and not just a social media.One Rumor circulated this week that Facebook is looking to change its name, and may be taking a page out of Google's playbook when it changed its name to <b>Alphabet</b> back in 2015.</p>\n<p>Last quarter Facebook was very careful with its outlook because of the year-over-year comps and ad targeting changes, mainly from iOS. So it will be interesting to see how big the impact was. And lastly, shareholders might want to get an update on the whole whistleblower situation. The resulting dip was in my opinion an opportunity to buy Facebook at a discount.</p>\n<h2>Twitter</h2>\n<p>Just like with Facebook and <b>Snap</b>, Twitter's results will give me better insight into social media ad spending. Since I'm a holder of <b>Pinterest</b> (unless <b>PayPal(PYPL)</b> acquires it), that will be crucial info. Besides that, I'm curious to know how the new features on Twitter are doing. The last time we got some numbers regarding Super Follows, those weren't great. In the first two weeks of the launch, it generated just $6,000. The advertising targeting on Twitter is horrible compared to other platforms, so I'm curious to see how well the company has performed this quarter. Total revenue is expected to be between $1.22 billion and $1.3 billion.</p>\n<h2>Teladoc</h2>\n<p>As I wrote at the start of the month, a broken stock does not equal a broken company. I think it's about time the market stopped seeing Teladoc as just a COVID-19 play but as a major revolutionary upgrade to the current state of healthcare. Despite the stock being down 30% year to date, the company continues to grow each and every quarter. The company expects to grow revenue 78%, and total visits 23% year over year at the midpoint.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks to Keep an Eye on Ahead of Next Week's Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks to Keep an Eye on Ahead of Next Week's Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-22 20:15 GMT+8 <a href=https://www.fool.com/investing/2021/10/22/3-stocks-to-keep-an-eye-on-ahead-of-next-weeks-ear/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>I'll discuss the three stocks I'll be watching ahead of next week's earnings: Facebook(FB), Twitter(TWTR), and Teladoc. \nFacebook\nLast quarter it was all about the metaverse and how Mark Zuckerberg ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/22/3-stocks-to-keep-an-eye-on-ahead-of-next-weeks-ear/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWTR":"Twitter","TDOC":"Teladoc Health Inc."},"source_url":"https://www.fool.com/investing/2021/10/22/3-stocks-to-keep-an-eye-on-ahead-of-next-weeks-ear/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2177497008","content_text":"I'll discuss the three stocks I'll be watching ahead of next week's earnings: Facebook(FB), Twitter(TWTR), and Teladoc. \nFacebook\nLast quarter it was all about the metaverse and how Mark Zuckerberg wants Facebook to become a metaverse company and not just a social media.One Rumor circulated this week that Facebook is looking to change its name, and may be taking a page out of Google's playbook when it changed its name to Alphabet back in 2015.\nLast quarter Facebook was very careful with its outlook because of the year-over-year comps and ad targeting changes, mainly from iOS. So it will be interesting to see how big the impact was. And lastly, shareholders might want to get an update on the whole whistleblower situation. The resulting dip was in my opinion an opportunity to buy Facebook at a discount.\nTwitter\nJust like with Facebook and Snap, Twitter's results will give me better insight into social media ad spending. Since I'm a holder of Pinterest (unless PayPal(PYPL) acquires it), that will be crucial info. Besides that, I'm curious to know how the new features on Twitter are doing. The last time we got some numbers regarding Super Follows, those weren't great. In the first two weeks of the launch, it generated just $6,000. The advertising targeting on Twitter is horrible compared to other platforms, so I'm curious to see how well the company has performed this quarter. Total revenue is expected to be between $1.22 billion and $1.3 billion.\nTeladoc\nAs I wrote at the start of the month, a broken stock does not equal a broken company. I think it's about time the market stopped seeing Teladoc as just a COVID-19 play but as a major revolutionary upgrade to the current state of healthcare. Despite the stock being down 30% year to date, the company continues to grow each and every quarter. The company expects to grow revenue 78%, and total visits 23% year over year at the midpoint.","news_type":1},"isVote":1,"tweetType":1,"viewCount":489,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/851215189"}
精彩评论